Workboat Indexes
All News about Agex Therapeutics Inc
![](https://mms.businesswire.com/media/20240227338800/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/25/ibm_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/17/age.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231114746069/en/1404785/22/AGEX_logo_400x400.jpg)
AgeX Therapeutics Reports Third Quarter 2023 Financial Results
November 14, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230905994663/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://mms.businesswire.com/media/20230830587829/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://mms.businesswire.com/media/20230829713838/en/1877728/5/Serina_Logo_Full_Name_Stacked_with_Mark_Grey.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230814318651/en/1404785/22/AGEX_logo_400x400.jpg)
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
August 14, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230724163190/en/1404785/22/AGEX_logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230721797927/en/1404785/22/AGEX_logo_400x400.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/11/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/03/li_auto_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230523005394/en/1404785/22/AGEX_logo_400x400.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://mms.businesswire.com/media/20230512005083/en/1404785/22/AGEX_logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230426005312/en/1404785/22/AGEX_logo_400x400.jpg)
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
April 26, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230331005104/en/1404785/22/AGEX_logo_400x400.jpg)
![](https://mms.businesswire.com/media/20221125005303/en/1404785/4/AGEX_logo_400x400.jpg)
![](https://mms.businesswire.com/media/20221110005519/en/1404785/4/AGEX_logo_400x400.jpg)
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
November 10, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220812005093/en/1404785/4/AGEX_logo_400x400.jpg)
AgeX Therapeutics Reports Second Quarter 2022 Financial Results
August 12, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/07/06/image_3.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220518005457/en/1404785/4/AGEX_logo_400x400.jpg)
![](https://mms.businesswire.com/media/20220513005126/en/1404785/4/AGEX_logo_400x400.jpg)
![](https://mms.businesswire.com/media/20220329005383/en/1404388/5/AGEXresizedlogo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/26/yesterdays_movers.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.